scispace - formally typeset
S

Samuel H. Payne

Researcher at Brigham Young University

Publications -  130
Citations -  8534

Samuel H. Payne is an academic researcher from Brigham Young University. The author has contributed to research in topics: Proteogenomics & Proteomics. The author has an hindex of 34, co-authored 119 publications receiving 5725 citations. Previous affiliations of Samuel H. Payne include Ludwig Institute for Cancer Research & J. Craig Venter Institute.

Papers
More filters
Journal ArticleDOI

Proteogenomic characterization of human colon and rectal cancer

Bing Zhang, +64 more
- 18 Sep 2014 - 
TL;DR: Integrated proteogenomic analysis provides functional context to interpret genomic abnormalities and affords a new paradigm for understanding cancer biology.
Journal ArticleDOI

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

TL;DR: A view of how the somatic genome drives the cancer proteome and associations between protein and post-translational modification levels and clinical outcomes in HGSC is provided.
Journal ArticleDOI

A Multidimensional Chromatography Technology for In-depth Phosphoproteome Analysis

TL;DR: A multidimensional chromatography technology, combining IMAC, hydrophilic interaction chromatography, and reverse phase LC, for phosphopeptide purification and fractionation is developed, suited for in-depth phosphoproteome studies.
Journal ArticleDOI

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.

Suhas Vasaikar, +82 more
- 02 May 2019 - 
TL;DR: Comparative proteomic and phosphoproteomic analysis of paired tumor and normal adjacent tissues produced a catalog of colon cancer-associated proteins and phosphosites, including known and putative new biomarkers, drug targets, and cancer/testis antigens, which suggested glycolysis as a potential target to overcome the resistance of MSI-H tumors to immune checkpoint blockade.
Journal ArticleDOI

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.

David J. Clark, +224 more
- 31 Oct 2019 - 
TL;DR: A large-scale proteogenomic analysis of ccRCC is reported to discern the functional impact of genomic alterations and provides evidence for rational treatment selection stemming fromccRCC pathobiology.